Omicron SARS-CoV-2 Variants in an In Silico Genomic Comparison Study with the Original Wuhan Strain and WHO-Recognized Variants of Concern

Adiga R, Nayak V. Emergence of novel SARS-CoV-2 variants in India: second wave. J Infect Dev Ctries. 2021 Nov;15(11):1578–1583. https://doi.org/10.3855/jidc.15484Adiga R Nayak V Emergence of novel SARS-CoV-2 variants in India: second wave J Infect Dev Ctries 2021 Nov15111578 1583 https://doi.org/10.3855/jidc.1548410.3855/jidc.1548434898481Search in Google Scholar

Ahmed-Abakur EH, Alnour TMS. Genetic variations among SARS-CoV-2 strains isolated in China. Gene Rep. 2020 Dec;21:100925. https://doi.org/10.1016/j.genrep.2020.100925Ahmed-Abakur EH Alnour TMS Genetic variations among SARS-CoV-2 strains isolated in China Gene Rep 2020 Dec21100925 https://doi.org/10.1016/j.genrep.2020.10092510.1016/j.genrep.2020.100925783452033521384Search in Google Scholar

Ahmed-Abakur EH, Ullah MF, Elssaig EH, Alnour TMS. In-silico genomic landscape characterization and evolution of SARS-CoV-2 variants isolated in India shows significant drift with high frequency of mutations. Saudi J Biol Sci. 2022 May;29(5):3494–3501. https://doi.org/10.1016/j.sjbs.2022.02.030Ahmed-Abakur EH Ullah MF Elssaig EH Alnour TMS In-silico genomic landscape characterization and evolution of SARS-CoV-2 variants isolated in India shows significant drift with high frequency of mutations Saudi J Biol Sci 2022 May2953494 3501 https://doi.org/10.1016/j.sjbs.2022.02.03010.1016/j.sjbs.2022.02.030887576635233173Search in Google Scholar

Andreata-Santos R, Janini LMR, Durães-Carvalho R. From Alpha to Omicron SARS‑CoV‑2 variants: what their evolutionary signatures can tell us? J Med Virol. 2022 May;94(5):1773–1776. https://doi.org/10.1002/jmv.27555Andreata-Santos R Janini LMR Durães-Carvalho R From Alpha to Omicron SARS‑CoV‑2 variants: what their evolutionary signatures can tell us? J Med Virol 2022 May9451773 1776 https://doi.org/10.1002/jmv.2755510.1002/jmv.27555901555834978091Search in Google Scholar

Callaway E. Beyond Omicron: what’s next for COVID’s viral evolution. Nature. 2021 Dec;600(7888):204–207. https://doi.org/10.1038/d41586-021-03619-8Callaway E Beyond Omicron: what’s next for COVID’s viral evolution Nature 2021 Dec6007888204 207 https://doi.org/10.1038/d41586-021-03619-810.1038/d41586-021-03619-834876665Search in Google Scholar

Cao C, Cai Z, Xiao X, Rao J, Chen J, Hu N, Yang M, Xing X, Wang Y, Li M, et al. The architecture of the SARS-CoV-2 RNA genome inside virion. Nat Commun. 2021 Jun;12(1):3917. https://doi.org/10.1038/s41467-021-22785-xCao C Cai Z Xiao X Rao J Chen J Hu N Yang M Xing X Wang Y Li M et al The architecture of the SARS-CoV-2 RNA genome inside virion Nat Commun 2021 Jun1213917 https://doi.org/10.1038/s41467-021-22785-x10.1038/s41467-021-22785-x822578834168138Search in Google Scholar

CDC. Science brief: Omicron (B.1.1.529) variant [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2021 [cited 2022 Mar 18]. Available from https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-Omicron-variant.htmlCDC Science brief: Omicron (B.1.1.529) variant [Internet] Atlanta (USA) Centers for Disease Control and Prevention; 2021 [cited 2022 Mar 18]. Available from https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-Omicron-variant.htmlSearch in Google Scholar

Choi JY, Smith DM. SARS-CoV-2 variants of concern. Yonsei Med J. 2021 Nov;62(11):961–968. https://doi.org/10.3349/ymj.2021.62.11.961Choi JY Smith DM SARS-CoV-2 variants of concern Yonsei Med J 2021 Nov6211961 968 https://doi.org/10.3349/ymj.2021.62.11.96110.3349/ymj.2021.62.11.961854247434672129Search in Google Scholar

Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985 Jul;39(4):783–791. https://doi.org/10.1111/j.1558-5646.1985.tb00420.xFelsenstein J Confidence limits on phylogenies: an approach using the bootstrap Evolution 1985 Jul394783 791 https://doi.org/10.1111/j.1558-5646.1985.tb00420.x10.1111/j.1558-5646.1985.tb00420.x28561359Search in Google Scholar

Gao SJ, Guo H, Luo G. Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert! J Med Virol. 2022 Apr; 94(4): 1255–1256. https://doi.org/10.1002/jmv.27491Gao SJ Guo H Luo G Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert! J Med Virol 2022 Apr 944 1255 1256 https://doi.org/10.1002/jmv.2749110.1002/jmv.27491901539734850421Search in Google Scholar

Gowrisankar A, Priyanka TMC, Banerjee S. Omicron: a mysterious variant of concern. Eur Phys J Plus. 2022;137(1):100. https://doi.org/10.1140/epjp/s13360-021-02321-yGowrisankar A Priyanka TMC Banerjee S Omicron: a mysterious variant of concern Eur Phys J Plus 20221371100 https://doi.org/10.1140/epjp/s13360-021-02321-y10.1140/epjp/s13360-021-02321-y874375035036269Search in Google Scholar

Gu H, Krishnan P, Ng DYM, Chang LDJ, Liu GYZ, Cheng SSM, Hui MMY, Fan MCY, Wan JHL, Lau LHK, et al. Probable transmission of SARS-CoV-2 Omicron variant in quarantine hotel, Hong Kong, China, November 2021. Emerg Infect Dis. 2022 Feb; 28(2): 460–462. https://doi.org/10.3201/eid2802.212422Gu H Krishnan P Ng DYM Chang LDJ Liu GYZ Cheng SSM Hui MMY Fan MCY Wan JHL Lau LHK et al Probable transmission of SARS-CoV-2 Omicron variant in quarantine hotel, Hong Kong, China, November 2021 Emerg Infect Dis 2022 Feb 282 460 462 https://doi.org/10.3201/eid2802.21242210.3201/eid2802.212422879867834860154Search in Google Scholar

Hu J, Peng P, Cao X, Wu K, Chen J, Wang K, Tang N, Huang AL. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol Immunol. 2022 Feb;19(2):293–295. https://doi.org/10.1038/s41423-021-00836-zHu J Peng P Cao X Wu K Chen J Wang K Tang N Huang AL Increased immune escape of the new SARS-CoV-2 variant of concern Omicron Cell Mol Immunol 2022 Feb192293 295 https://doi.org/10.1038/s41423-021-00836-z10.1038/s41423-021-00836-z874934735017716Search in Google Scholar

Isidoro C, Chiung-Fang Chang A, Sheen LY. Natural products as a source of novel drugs for treating SARS-CoV2 infection. J Tradit Complement Med. 2022 Jan;12(1):1–5. https://doi.org/10.1016/j.jtcme.2022.02.001Isidoro C Chiung-Fang Chang A Sheen LY Natural products as a source of novel drugs for treating SARS-CoV2 infection J Tradit Complement Med 2022 Jan1211 5 https://doi.org/10.1016/j.jtcme.2022.02.00110.1016/j.jtcme.2022.02.001882297035155135Search in Google Scholar

Jia H, Wang H, Cao L, Lai Z, Cheng Z, Chen Q, Liu T, Liu X, Wen Y, Xu C, et al. Genetic analysis of a SARS-CoV-2 Omicron variant from a Chinese traveller returning from overseas. Emerg Microbes Infect. 2022 Dec;11(1):306–309. https://doi.org/10.1080/22221751.2022.2025747Jia H Wang H Cao L Lai Z Cheng Z Chen Q Liu T Liu X Wen Y Xu C et al Genetic analysis of a SARS-CoV-2 Omicron variant from a Chinese traveller returning from overseas Emerg Microbes Infect 2022 Dec111306 309 https://doi.org/10.1080/22221751.2022.202574710.1080/22221751.2022.2025747882079534983331Search in Google Scholar

Kandeel M, Mohamed MEM, Abd El-Lateef HM, Venugopala KN, El-Beltagi HS. Omicron variant genome evolution and phylogenetics. J Med Virol. 2022 Apr;94(4):1627–1632. https://doi.org/10.1002/jmv.27515Kandeel M Mohamed MEM Abd El-Lateef HM Venugopala KN El-Beltagi HS Omicron variant genome evolution and phylogenetics J Med Virol 2022 Apr9441627 1632 https://doi.org/10.1002/jmv.2751510.1002/jmv.27515901534934888894Search in Google Scholar

Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529) – variant of concern – molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8019–8022. https://doi.org/10.26355/eurrev_202112_27653Kannan S Shaik Syed Ali P Sheeza A Omicron (B.1.1.529) – variant of concern – molecular profile and epidemiology: a mini review Eur Rev Med Pharmacol Sci 2021 Dec25248019 8022 https://doi.org/10.26355/eurrev_202112_27653Search in Google Scholar

Kannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS‑CoV-2 variant: unique features and their impact on pre-existing antibodies. J Autoimmun. 2022 Jan;126: 102779. https://doi.org/10.1016/j.jaut.2021.102779Kannan SR Spratt AN Sharma K Chand HS Byrareddy SN Singh K Omicron SARS‑CoV-2 variant: unique features and their impact on pre-existing antibodies J Autoimmun 2022 Jan126 102779 https://doi.org/10.1016/j.jaut.2021.10277910.1016/j.jaut.2021.102779866630334915422Search in Google Scholar

Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021 Dec;398(10317): 2126–2128. https://doi.org/10.1016/S0140-6736(21)02758-6Karim SSA Karim QA Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic Lancet 2021 Dec39810317 2126 2128 https://doi.org/10.1016/S0140-6736(21)02758-610.1016/S0140-6736(21)02758-6864067334871545Search in Google Scholar

Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020 Jun;19:100682. https://doi.org/10.1016/j.genrep.2020.100682Khailany RA Safdar M Ozaslan M Genomic characterization of a novel SARS-CoV-2 Gene Rep 2020 Jun19100682 https://doi.org/10.1016/j.genrep.2020.10068210.1016/j.genrep.2020.100682716148132300673Search in Google Scholar

Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, et al; Sheffield COVID-19 Genomics Group. Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020 Aug;182(4):812–827.e19. https://doi.org/10.1016/j.cell.2020.06.043Korber B Fischer WM Gnanakaran S Yoon H Theiler J Abfalterer W Hengartner N Giorgi EE Bhattacharya T Foley B et al; Sheffield COVID-19 Genomics Group Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus Cell 2020 Aug1824812 827e19 https://doi.org/10.1016/j.cell.2020.06.04310.1016/j.cell.2020.06.043733243932697968Search in Google Scholar

Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J Med Virol. 2022 Apr;94(4):1641–1649. https://doi.org/10.1002/jmv.27526Kumar S Thambiraja TS Karuppanan K Subramaniam G Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein J Med Virol 2022 Apr9441641 1649 https://doi.org/10.1002/jmv.2752610.1002/jmv.2752634914115Search in Google Scholar

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb;395(10224):565–574. https://doi.org/10.1016/S0140-6736(20)30251-8Lu R Zhao X Li J Niu P Yang B Wu H Wang W Song H Huang B Zhu N et al Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet 2020 Feb39510224565 574 https://doi.org/10.1016/S0140-6736(20)30251-810.1016/S0140-6736(20)30251-8715908632007145Search in Google Scholar

Lupala CS, Ye Y, Chen H, Su XD, Liu H. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Biochem Biophys Res Commun. 2022 Jan;590:34–41. https://doi.org/10.1016/j.bbrc.2021.12.079Lupala CS Ye Y Chen H Su XD Liu H Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor Biochem Biophys Res Commun 2022 Jan59034 41 https://doi.org/10.1016/j.bbrc.2021.12.07910.1016/j.bbrc.2021.12.079870263234968782Search in Google Scholar

Mahase E. Covid-19: What do we know about omicron sublineages? BMJ. 2022 Feb;376:o358. https://doi.org/10.1136/bmj.o358Mahase E Covid-19: What do we know about omicron sublineages? BMJ 2022 Feb376o358 https://doi.org/10.1136/bmj.o35810.1136/bmj.o35835149516Search in Google Scholar

Mallapaty S. Where did Omicron come from? Three key theories. Nature. 2022 Feb;602(7895):26–28. https://doi.org/10.1038/d41586-022-00215-2Mallapaty S Where did Omicron come from? Three key theories Nature 2022 Feb602789526 28 https://doi.org/10.1038/d41586-022-00215-210.1038/d41586-022-00215-235091701Search in Google Scholar

Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, et al.; Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. 2021 Nov;599(7883): 114–119. https://doi.org/10.1038/s41586-021-03944-yMlcochova P Kemp SA Dhar MS Papa G Meng B Ferreira IATM Datir R Collier DA Albecka A Singh S et al Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion Nature 2021 Nov5997883 114 119 https://doi.org/10.1038/s41586-021-03944-y10.1038/s41586-021-03944-y856622034488225Search in Google Scholar

Mohapatra RK, Sarangi AK, Kandi V, Azam M, Tiwari R, Dhama K. Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario. J Med Virol. 2022 May;94(5):1780–1783. https://doi.org/10.1002/jmv.27561Mohapatra RK Sarangi AK Kandi V Azam M Tiwari R Dhama K Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario J Med Virol 2022 May9451780 1783 https://doi.org/10.1002/jmv.2756110.1002/jmv.27561901545434964506Search in Google Scholar

Poudel S, Ishak A, Perez-Fernandez J, Garcia E, León-Figueroa DA, Romaní L, Bonilla-Aldana DK, Rodriguez-Morales AJ. Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – what is known so far? Travel Med Infect Dis. 2022 Jan-Feb;45:102234. https://doi.org/10.1016/j.tmaid.2021.102234Poudel S Ishak A Perez-Fernandez J Garcia E León-Figueroa DA Romaní L Bonilla-Aldana DK Rodriguez-Morales AJ Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – what is known so far? Travel Med Infect Dis 2022 Jan-Feb45102234 https://doi.org/10.1016/j.tmaid.2021.10223410.1016/j.tmaid.2021.102234866666234896326Search in Google Scholar

Quarleri J, Galvan V, Delpino MV. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load. Geroscience. 2022 Feb;44(1):53–56. https://doi.org/10.1007/s11357-021-00500-4Quarleri J Galvan V Delpino MV Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load Geroscience 2022 Feb44153 56 https://doi.org/10.1007/s11357-021-00500-410.1007/s11357-021-00500-4868330934921354Search in Google Scholar

Rauf A, Abu-Izneid T, Khalil AA, Hafeez N, Olatunde A, Rahman M, Semwal P, Al-Awthan YS, Bahattab OS, Khan IN, et al. Nanoparticles in clinical trials of COVID-19: an update. Int J Surg. 2022 Aug;104:106818. https://doi.org/10.1016/j.ijsu.2022.106818Rauf A Abu-Izneid T Khalil AA Hafeez N Olatunde A Rahman M Semwal P Al-Awthan YS Bahattab OS Khan IN et al Nanoparticles in clinical trials of COVID-19: an update Int J Surg 2022 Aug104106818 https://doi.org/10.1016/j.ijsu.2022.10681810.1016/j.ijsu.2022.106818935976935953020Search in Google Scholar

Rudrapal M, Khairnar SJ, Borse LB, Jadhav AG. Coronavirus Disease-2019 (COVID-19): an updated review. Drug Res (Stuttg). 2020 Sep;70(9):389–400. https://doi.org/10.1055/a-1217-2397Rudrapal M Khairnar SJ Borse LB Jadhav AG Coronavirus Disease-2019 (COVID-19): an updated review Drug Res (Stuttg) 2020 Sep709389 400 https://doi.org/10.1055/a-1217-239710.1055/a-1217-2397751636932746481Search in Google Scholar

Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987 Jul;4(4): 406–425. https://doi.org/10.1093/oxfordjournals.molbev.a040454Saitou N Nei M The neighbor-joining method: a new method for reconstructing phylogenetic trees Mol Biol Evol 1987 Jul44 406 425 https://doi.org/10.1093/oxfordjournals.molbev.a04045410.1093/oxfordjournals.molbev.a0404543447015Search in Google Scholar

Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK, Abdel-Moneim AS. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. J Med Virol. 2022 Apr;94(4):1738–1744. https://doi.org/10.1002/jmv.27524Saxena SK Kumar S Ansari S Paweska JT Maurya VK Tripathi AK Abdel-Moneim AS Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective J Med Virol 2022 Apr9441738 1744 https://doi.org/10.1002/jmv.2752410.1002/jmv.2752434905235Search in Google Scholar

Sharma V, Rai H, Gautam DNS, Prajapati PK, Sharma R. Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant. J Med Virol. 2022 May;94(5):1876–1885. https://doi.org/10.1002/jmv.27626Sharma V Rai H Gautam DNS Prajapati PK Sharma R Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant J Med Virol 2022 May9451876 1885 https://doi.org/10.1002/jmv.2762610.1002/jmv.27626901559635083761Search in Google Scholar

Shishir TA, Naser IB, Faruque SM. In silico comparative genomics of SARS-CoV-2 to determine the source and diversity of the pathogen in Bangladesh. PLoS One. 2021 Jan;16(1):e0245584. https://doi.org/10.1371/journal.pone.0245584Shishir TA Naser IB Faruque SM In silico comparative genomics of SARS-CoV-2 to determine the source and diversity of the pathogen in Bangladesh PLoS One 2021 Jan161e0245584 https://doi.org/10.1371/journal.pone.024558410.1371/journal.pone.0245584781702233471859Search in Google Scholar

Sofi MS, Hamid A, Bhat SU. SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment. Biosaf Health. 2020 Dec;2(4):217–225. https://doi.org/10.1016/j.bsheal.2020.11.002Sofi MS Hamid A Bhat SU SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment Biosaf Health 2020 Dec24217 225 https://doi.org/10.1016/j.bsheal.2020.11.00210.1016/j.bsheal.2020.11.002764888833196035Search in Google Scholar

Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA. 2004 Jul;101(30):11030–11035. https://doi.org/10.1073/pnas.0404206101Tamura K Nei M Kumar S Prospects for inferring very large phylogenies by using the neighbor-joining method Proc Natl Acad Sci USA 2004 Jul1013011030 11035 https://doi.org/10.1073/pnas.040420610110.1073/pnas.040420610149198915258291Search in Google Scholar

Tan Z, Chen Z, Yu A, Li X, Feng Y, Zhao X, Xu W, Su X. The first two imported cases of SARS-CoV-2 Omicron variant – Tianjin Municipality, China, December 13, 2021. China CDC Wkly. 2022 Jan; 4(4):76–77. https://doi.org/10.46234/ccdcw2021.266Tan Z Chen Z Yu A Li X Feng Y Zhao X Xu W Su X The first two imported cases of SARS-CoV-2 Omicron variant – Tianjin Municipality, China, December 13, 2021 China CDC Wkly 2022 Jan 4476 77 https://doi.org/10.46234/ccdcw2021.26610.46234/ccdcw2021.266883744335186373Search in Google Scholar

Thakur V, Ratho RK. OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear. J Med Virol. 2022 May; 94(5):1821–1824. https://doi.org/10.1002/jmv.27541Thakur V Ratho RK OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear J Med Virol 2022 May 9451821 1824 https://doi.org/10.1002/jmv.2754110.1002/jmv.2754134936120Search in Google Scholar

Vardhan S, Sahoo SK. Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid. Comput Biol Med. 2022a May; 144: 105367. https://doi.org/10.1016/j.compbiomed.2022.105367Vardhan S Sahoo SK Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid Comput Biol Med 2022a May 144 105367 https://doi.org/10.1016/j.compbiomed.2022.10536710.1016/j.compbiomed.2022.105367888668735247766Search in Google Scholar

Vardhan S, Sahoo SK. Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations. J Tradit Complement Med. 2022b Jan;12(1):44–54. https://doi.org/10.1016/j.jtcme.2021.12.002Vardhan S Sahoo SK Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations J Tradit Complement Med 2022b Jan12144 54 https://doi.org/10.1016/j.jtcme.2021.12.00210.1016/j.jtcme.2021.12.002866629334926189Search in Google Scholar

Wang L, Cheng G. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa. J Med Virol. 2022 Apr; 94(4): 1728–1733. https://doi.org/10.1002/jmv.27516Wang L Cheng G Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa J Med Virol 2022 Apr 944 1728 1733 https://doi.org/10.1002/jmv.2751610.1002/jmv.2751634897752Search in Google Scholar

Wang R, Chen J, Wei GW. Mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America. J Phys Chem Lett. 2021 Dec;12(49):11850–11857. https://doi.org/10.1021/acs.jpclett.1c03380Wang R Chen J Wei GW Mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America J Phys Chem Lett 2021 Dec124911850 11857 https://doi.org/10.1021/acs.jpclett.1c0338010.1021/acs.jpclett.1c03380867243534873910Search in Google Scholar

Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z, Lu X, Zhang Y, Ma L, Gu W, et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol. 2020 Jun;17(6):621–630. https://doi.org/10.1038/s41423-020-0458-zYi C Sun X Ye J Ding L Liu M Yang Z Lu X Zhang Y Ma L Gu W et al Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies Cell Mol Immunol 2020 Jun176621 630 https://doi.org/10.1038/s41423-020-0458-z10.1038/s41423-020-0458-z722745132415260Search in Google Scholar

Zhang X, Wu S, Wu B, Yang Q, Chen A, Li Y, Zhang Y, Pan T, Zhang H, He X. SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance. Signal Transduct Target Ther. 2021 Dec;6(1):430. https://doi.org/10.1038/s41392-021-00852-5Zhang X Wu S Wu B Yang Q Chen A Li Y Zhang Y Pan T Zhang H He X SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance Signal Transduct Target Ther 2021 Dec61430 https://doi.org/10.1038/s41392-021-00852-510.1038/s41392-021-00852-5867897134921135Search in Google Scholar